Hofmann is a fourth-year medical student in the M.D./M.P.H. dual degree program at the University of Miami Miller School of ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

Vijay Kumar, acting director of the office that reviews cell and gene therapies at the Food and Drug Administration, is ...

The Food and Drug Administration on Monday published the names of eight new panelists who will serve on a committee advising ...

Some housekeeping: Next week’s Health Care Inc. will come out Tuesday, July 7, instead of Monday. It’ll be a special edition ...

John Wilkerson, a Washington correspondent, is the author of D.C. Diagnosis, a twice-weekly newsletter about the politics and policy of health and medicine. John writes about the politics of health ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — Abivax on Monday night ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Five New England states are among 26 that sued the federal government on Monday to block work requirements for Medicaid enrollees that are expected to cost hundreds of thousands of people in ...

Tara covers the business of health care. Her stories focus on hospitals, doctors, and how their business practices affect patients — especially when private equity gets involved. She also writes about ...

The hospital operator Nutex enriched itself by exploiting loopholes in laws meant to protect patients, STAT found.

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — The chair of the ...